Emerging strategies for TNBC with early clinical data: new chemoimmunotherapy strategies
Sign Up to like & getrecommendations! Published in 2022 at "Breast Cancer Research and Treatment"
DOI: 10.1007/s10549-022-06547-x
Abstract: The use of immune checkpoint inhibitors in combination with chemotherapy for the treatment of triple-negative breast cancer is becoming more widespread as efficacy data accumulates. However, outcomes remain less than optimal and not all patients… read more here.
Keywords: immune checkpoint; breast cancer; checkpoint; clinical data ... See more keywords